Clinical Trial Detail

NCT ID NCT02463799
Title Ph 2 Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPC
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Johns Hopkins University
Indications

prostate adenocarcinoma

Therapies

Radium Ra 223 dichloride

Sipuleucel-T

Age Groups: adult

No variant requirements are available.